Global Clinical Impact: Education, Tools, and Resources to Optimize the Care of Patients With Relapsed/Refractory MCL

Review latest practice-changing data and gain global expert insight on the integration of emerging BTK inhibitors into the care of patients with relapsed/refractory MCL including a roundtable of regional impacts of the data an on-demand webcast focused commentaries and Interactive Decision Support Tools for personalized management recommendations from internationally recognized experts.

Share

Program Content

Activities

Noncovalent BTKis in MCL
Noncovalent BTK Inhibitors in Mantle Cell Lymphoma: What You Should Know
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2022

Expires: October 19, 2023

View Activity
FAQs: BTKis for R/R MCL
FAQs: Optimizing the Care of Patients With Relapsed/Refractory MCL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2023

View Activity

Activities

BTK Inhibitors in R/R MCL
Experts Discuss Advances in the Use of BTK Inhibitors for the Treatment of Relapsed/Refractory MCL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2023

Expires: January 16, 2024

View Activity

Activities

BTK Inhibitors in MCL
Differences in Mechanism of Action and Selectivity of Covalent and Non-Covalent BTK Inhibitors
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 29, 2022

Expires: November 28, 2023

View Activity

Activities

BTK Inhibitors in R/R MCL
Experts Discuss Advances in the Use of BTK Inhibitors for the Treatment of Relapsed/Refractory MCL
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 20, 2023

Expires: March 19, 2024

View Activity

Activities

IDST: MCL
Interactive Decision Support Tool: MCL Expert Treatment Guidance
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2023

View Activity
IDST: Global MCL Therapy
Interactive Decision Support Tool: Global MCL Expert Treatment Guidance
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 29, 2023

View Activity

Faculty

cover img faculity

Julie M. Vose, MD, MBA

Newmann M. and Milde E. Harris Professor
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

cover img faculity

Stephen Ansell, MD, PhD

Professor of Medicine
Department of Hematology
Mayo Clinical Cancer Center
Rochester, Minnesota

cover img faculity

Ian W. Flinn, MD, PhD

Director, Lymphoma Research 
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Olivier Hermine, MD, PhD

Professor
Department of Hematology
Institut Imagine
Necker Hosptial
Paris, France

cover img faculity

Marco Ladetto, MD

Associate Professor
Dipartimento di Medicina Traslazionale
Università del Piemonte Orientale
Vercelli/Novara/Alessandria, Piedmont, Italy
Director of Hematology Oncology
SCDU Ematologia
AO SS Antonio E Biagio e Cesare Arrigo
Alessandria, Piedmont, Italy

cover img faculity

John P. Leonard, MD

Senior Associate Dean for Innovation and initiatives
Chair (Interim), Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York

cover img faculity

Ana Marin-Niebla, MD, PhD

Medical Specialist in Onco-Hematology
Senior Consultant in Hematology
Department of Hematology
Hospital Universitario Vall d'Hebron
Barcelona, Spain

cover img faculity

Guilherme Perini, MD

Medical Hematologist
Department of Hematology
Hospital Israelita Albert Einstein
Sao Paulo, Brazil

cover img faculity

Max Topp, MD

Professor
Head of Hematology
Department of Hematology
Universitätsklinikum Würzburg
Würzburg, Germany

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly